Neutralizing neutrophils

Genentech finds a neutrophil inflammation pathway

Scientists at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) uncovered a new role for a known kinase in neutrophil activation and blocked the protein to treat inflammatory diseases. Pathway data suggest targeting the kinase could produce superior anti-inflammatory drugs, but the question is whether the compounds can avoid risking serious infections.

According to principal investigator Ali Zarrin, a senior scientist at Genentech, neutrophils

Read the full 647 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers